Trademark Overview
On Wednesday, March 25, 2026, a trademark application was filed for REIMAGINE IMMUNOTHERAPY with the United States Patent and Trademark Office. The USPTO has given the REIMAGINE IMMUNOTHERAPY trademark a serial number of 99724695. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, March 25, 2026. This trademark is owned by Therakos Holdings USA, LLC. The REIMAGINE IMMUNOTHERAPY trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations for cellular therapy for the treatment of immune system related diseases and disorders, autoimmune diseases, cancer, inflammation and autoinflammation diseases by extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, cellular therapies, and photopheresis
medical devices, namely, therapeutic medical device for extracting blood from the body, separating blood, treating it extra corporally, and returning it to the body, used for extra corporeal photopheresis, extra corporeal photo immune therapy, extra corporeal photo chemotherapy, and cellular therapies
Medical services, namely, extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, cellular therapies, and photopheresis